PRIVATE ASSET MANAGEMENT INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRIVATE ASSET MANAGEMENT INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2021$279,000
+17.2%
20,657
+56.1%
0.03%
+6.2%
Q3 2021$238,000
-65.5%
13,231
-67.1%
0.03%
-65.2%
Q2 2021$689,000
-14.9%
40,156
-0.9%
0.09%
-18.6%
Q1 2021$810,000
+27.8%
40,506
+8.6%
0.11%
+18.9%
Q4 2020$634,000
+3.1%
37,306
+0.7%
0.10%
-6.9%
Q3 2020$615,000
-26.7%
37,056
+2.3%
0.10%
-31.5%
Q2 2020$839,000
+57.7%
36,231
+21.7%
0.15%
+33.0%
Q1 2020$532,000
+25.8%
29,781
+51.9%
0.11%
+62.3%
Q4 2019$423,00019,6000.07%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2020
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders